When used with a common heart scan, machine learning, a type of artificial intelligence (AI), does better than conventional risk models at predicting heart attacks and other cardiac events, according to a study published in the journal Radiology.

Montefiore Nyack Hospital, an acute care hospital in Rockland County, N.Y., announced it is utilizing artificial intelligence (AI) software to assist in identifying urgent life-threatening conditions on patient computed tomography (CT) scans. The commercial solution from medical AI company Aidoc automatically prioritizes critical medical conditions, ensuring patients are diagnosed and treated faster. Montefiore Nyack is the first regional hospital in the New York metropolitan area to use Aidoc, joining more than 160 medical centers worldwide.

Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint's Transpara products to breast imaging clinics in the United States, Australia, New Zealand and parts of Asia. Transpara is designed to assist radiologists with the reading of mammograms and is one of the first next-generation artificial intelligence (AI) applications for detecting breast cancer in screening mammograms to gain 510(k) clearance from the U.S. Food & Drug Administration (FDA).

The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment.

Clinical trials are a critical tool for getting new treatments to people who need them, but research shows that difficulty finding the right volunteer subjects can undermine the effectiveness of these studies. Researchers at Cincinnati Children’s Hospital Medical Center designed and tested a new computerized solution that used artificial intelligence (AI) to effectively identify eligible subjects from electronic health records (EHRs), allowing busy clinical staff to focus their limited time on evaluating the highest quality candidates.

The members of the American Society for Radiation Oncology (ASTRO) elected four new officers to ASTRO’s Board of Directors. Laura Dawson, M.D., FASTRO, will begin her term as president-elect in September during ASTRO’s 61st Annual Meeting, Sept. 15-18 in Chicago, alongside Neha Vapiwala, M.D., the new secretary/treasurer-elect; Constantine Mantz, M.D., the new health policy council vice-chair; and Brian Marples, Ph.D., the new science council vice-chair.